Bladder instillations of gentamicin to treat refractory recurrent urinary tract infection

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018).

Article  Google Scholar 

Mulvey, M. A., Schilling, J. D. & Hultgren, S. J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69, 4572–4579 (2001).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fisher, R. A., Gollan, B. & Helaine, S. Persistent bacterial infections and persister cells. Nat. Rev. Microbiol. 15, 453–464 (2017).

Article  CAS  PubMed  Google Scholar 

Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).

Article  Google Scholar 

Sihra, N., Goodman, A., Zakri, R., Sahai, A. & Malde, S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat. Rev. Urol. 15, 750–776 (2018).

Article  PubMed  Google Scholar 

Rutherford, G. et al. Intravesical gentamicin treatment for recurrent urinary tract infections: a systematic review over the last two decades. J. Clin. Urol. 17, 536–544 (2024).

Article  Google Scholar 

Wan, J. et al. Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies. Urology 43, 531–536 (1994).

Article  CAS  PubMed  Google Scholar 

Cameron, A. P., Castrodad, P. M., Troost, J., Forchheimer, M. & Tate, D. G. Effectiveness and patient perspective on the use of intravesical gentamicin instillations to treat recurrent urinary tract infections in neurogenic lower urinary tract dysfunction. Neurourol. Urodyn. 43, 1916–1923 (2024).

Article  PubMed  Google Scholar 

Iacob, S. & Iacob, D. G. Infectious threats, the intestinal barrier, and its Trojan horse: dysbiosis. Front. Microbiol. 10, 1676 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Chitteti, P., Ekpeno, I., Morris-Laverick, J., Bezemer, S. & Nadeem, M. Is intravesical gentamicin the new gold standard to manage refractory urinary tract infections?—Experience from a dedicated multidisciplinary complex UTI clinic. Neurourol. Urodyn. https://doi.org/10.1002/nau.25635 (2024).

Article  PubMed  Google Scholar 

Comments (0)

No login
gif